The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
One Biosciences raises $17.5 million to accelerate clinical diagnostic platform development and expand partnerships.
Jul 21, 2025•11 months ago
Contract Type
funding
ParisBiotechnology
Description
One Biosciences has secured $17.5 million in Series A funding to enhance its clinical diagnostic platform and foster collaborations with pharmaceutical and biotech firms. The funding will support the development of their OneMap platform, improving precision medicine capabilities.
Company Information
Company
One Biosciences
Location
Paris, Ile De France, France
About
One Biosciences is a biotech company leveraging the power of single-cell analysis and A.I. to identify a new generation of precision medicine targets and develop new treatments. The company is advancing its pipeline across multiple ongoing projects in oncology and rare diseases.
Predictive Intelligence
Strategic
ML-powered predictions for One Biosciences's next move
ParisBiotechnology